Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Festival Offer
This Diwali, Light up your portfolio with MoneyWorks4me Superstars starting @ ₹ 7,999 ₹ 5,999 (Offer valid till 3rd Nov 21)

Emmessar Biotech & Nutrition submits copy of revised financial results

26 Dec 2015

Emmessar Biotech & Nutrition has submitted a copy of the Revised Financial Results for the period ended September 30, 2015 with the necessary corrections duly done in Profit Before Tax in the Segment wise section.

The above information is a part of company’s filings submitted to BSE.

 

 

 

Related Emmessar Biotech & Nutrition Ltd. Links:

Emmessar Biotech&Nut Share Price

28.75 0.70 (2.50%) Oct 26, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 813.55
Cipla 907.30
Dr. Reddy's Lab 4667.70
Aurobindo Pharma 703.80
Lupin 929.80
View more..
Sensex vs Emmessar Biotech&Nut
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback